Related Experiment Video
Updated: Aug 6, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
[Patent foramen ovale and migraine, a fortuitus association or a causal relationship?]
J Schoenen1, Ph Burette, P Materne
1Unité de Recherches sur les Céphalées, Service de Neurologie, CHR Citadelle, Liège, Belgique. jschoenen@ulg.ac.be
Abstract:
Epidemiologic studies have shown a clear comorbidity between migraine with aura and a patent foramen ovale (PFO). Under the age of 55, migraine with aura is a risk factor for ischemic stroke and a proportion of the latter is due to a PFO. It remains to be determined whether PFO is causally related to migraine attacks, or is a fortuitous association due to common genetic factors. Cortical spreading depression which is the underlying mechanism of the migrainous aura, could be favoured by a PFO. Several retrospective and uncontrolled studies suggest that percutaneous closure of a PFO for stroke or decompression illness in divers reduces frequency of migraine attacks with, but also without aura. Multicentric, prospective and controlled trials of this intervention in migraineurs are underway or in preparation. As long as their results are not known, there is no rationale for proposing PFO closure for migraine.
Insights
Migraine with aura is linked to patent foramen ovale (PFO). While PFO closure may reduce migraine frequency, definitive evidence from controlled trials is pending, so it is not currently recommended for migraine treatment.
Area of Science:
- Neurology
- Cardiology
- Genetics
Background:
- Migraine with aura (MWA) frequently co-occurs with patent foramen ovale (PFO).
- MWA is a risk factor for ischemic stroke in individuals under 55, with PFO implicated in some cases.
- The etiological relationship between PFO and MWA remains unclear, with possibilities including causal links or shared genetic factors.
Observation:
- Cortical spreading depression, the mechanism behind migrainous aura, might be facilitated by a PFO.
- Retrospective, uncontrolled studies indicate that percutaneous PFO closure, performed for stroke or decompression illness, may decrease migraine attack frequency.
- These observed benefits include reductions in migraines with and without aura.
Findings:
- Evidence suggests a potential link between PFO and migraine, with some studies showing reduced migraine frequency after PFO closure.
- The precise role of PFO in migraine pathophysiology requires further investigation.
- Current data is largely from uncontrolled studies, necessitating more rigorous research.
Implications:
- Prospective, controlled trials are underway to definitively assess the efficacy of PFO closure for migraine management.
- Until trial results are available, there is no established rationale for recommending PFO closure specifically for treating migraine.
- Further research will clarify the therapeutic potential of PFO intervention in patients with migraine and PFO.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...

